Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.

Jingwi EY, Abbas M, Ricks-Santi L, Winchester D, Beyene D, Day A, Naab TJ, Kassim OO, Dunston GM, Copeland RL, Kanaan YM. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men. Anticancer Res. 2015 Mar; 35(3):1549-58.

View in: PubMed

subject areas

Aged
Case-Control Studies
Genetic Predisposition to Disease
Haplotypes
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Prostate-Specific Antigen
Prostatic Neoplasms
Receptors, Calcitriol
Risk

authors with profiles

Muneer M. Abbas
Robert L. Copeland
Yasmine Kanaan

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support